Bristol-Myers Squibb

Bristol-Myers Squibb Completes Previously Announced Sale of its HIV R&D Portfolio to ViiV Healthcare
Yahoo
Mon, 02/22/16 - 09:55 pm
Bristol-Myers Squibb
HIV
ViiV Healthcare
Bristol-Myers Looks To A Promising Future
Yahoo/Benzinga
Wed, 02/17/16 - 10:43 am
Bristol-Myers Squibb
immuno-oncology
Bristol-Myers shares could rise 25 pct on cancer drug-Barron's
Yahoo/Reuters
Tue, 02/16/16 - 10:00 am
Bristol-Myers Squibb
Opdivo
3 Reasons Bristol-Myers Squibb Co Stock Could Rise
Motley Fool
Fri, 02/12/16 - 04:16 pm
Bristol-Myers Squibb
3 Potential Blockbusters Moving the Needle for Big Pharma in 2016
Motley Fool
Mon, 02/8/16 - 10:23 am
Big Pharma
JNJ
Novartis
Bristol-Myers Squibb
Darzalex
Entresto
Opdivo
BMS expects fast-growing Eliquis to take the lead over Xarelto, Pradaxa
Fierce Pharma Marketing
Wed, 02/3/16 - 05:30 pm
bloodthinners
Bristol-Myers Squibb
Eliquis
Xarelto
Pradaxa
Bayer
Pfizer
JNJ
Boehringer Ingelheim
Bristol-Myers, Pfizer and Eisai bet big biobucks on the Japanese market
Fierce Biotech
Mon, 02/1/16 - 11:20 pm
Japan
Bristol-Myers Squibb
Pfizer
Eisai
Bristol-Myers forecasts 2016 profit above Wall Street estimates
Yahoo/Reuters
Thu, 01/28/16 - 08:37 am
Bristol-Myers Squibb
earnings
Bristol-Myers Squibb (BMY) Closed Down as Analysts Expect Earnings Decline
TheStreet.com
Wed, 01/27/16 - 04:30 pm
Bristol-Myers Squibb
earnings
BMS' Opdivo evens the score in melanoma with two new FDA green lights
Fierce Pharma
Mon, 01/25/16 - 10:32 pm
Bristol-Myers Squibb
Opdivo
FDA
melanoma
US Big Pharma: What To Watch For In Q4 Results
Yahoo/Benzinga
Mon, 01/25/16 - 10:20 pm
earnings
Eli Lilly
JNJ
Bristol-Myers Squibb
AbbVie
Pfizer
Merck
Reasons to Expect Strong Earnings From Bristol-Myers
TheStreet.com
Mon, 01/25/16 - 09:50 am
earnings
Bristol-Myers Squibb
Bristol-Myers' Opdivo Gets Nod for Melanoma From U.K. Regulator
Bloomberg
Thu, 01/21/16 - 07:52 pm
Bristol-Myers Squibb
Opdivo
melanoma
UK
NICE
BMS, Lilly, Sanofi and Novartis top Big Pharma's growth fortunes for next decade: Analysts
Fierce Pharma
Wed, 01/20/16 - 09:33 pm
Eli Lilly
Sanofi
Bristol-Myers Squibb
Novartis
Bristol-Myers Squibb: A New Chapter, and the Beginning of Sustained Growth
Motley Fool
Fri, 01/15/16 - 02:26 pm
Bristol-Myers Squibb
Giovanni Caforio
Why Portola Pharmaceuticals Shares Jumped 82% in 2015
Motley Fool
Thu, 01/7/16 - 08:52 am
Portola Pharmaceuticals
andexanet alfa
FDA
Bristol-Myers Squibb
JNJ
Cancer Drugs: Strong Growth for Bristol’s Opdivo, Pfizer’s Ibrance
Barron's
Wed, 12/30/15 - 09:01 pm
Bristol-Myers Squibb
Opdivo
Pfizer
Ibrance
Pennywise And Billion-Foolish: Troubling Data For Pfizer's Ian Read
Forbes
Tue, 12/29/15 - 11:39 am
Pfizer
Ian Read
R&D
tax inversions
Bristol-Myers Squibb
This Is the Most Effective Way to Treat Lung Cancer, Study Shows
Motley Fool
Mon, 12/28/15 - 09:49 am
lung cancer
Galena Biopharma
Inovio
Merck
Bristol-Myers Squibb
GlaxoSmithKline On Path To Recovery
Bidness, ETC
Sun, 12/20/15 - 04:37 pm
GSK
ViiV Healthcare
Bristol-Myers Squibb

Pages